SCI & TECH● LOWAug 3 · Aug 3, 2026, 1:28 PM
Zai Lab receives Orphan Drug status for ADC for neuroendocrine carcinomas
Seeking Alpha Tech
Zai Lab has been granted Orphan Drug status for its ADC, a drug intended for neuroendocrine carcinomas. This designation is a key step in the development of treatments for rare diseases.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Sci & Tech
SCI & TECH53m agoNvidia to buy open-source AI hub Hugging Face for $12.9bnEuroNews [en]SCI & TECH54m agoNyla Stone, the singer who doesn't exist, became a viral phenomenon and ended up clashing with a real womanClarínSCI & TECH1h agoIs TECNO’s CAMON Slim the future of smartphones?Premium TimesSCI & TECH1h agoChemours (CC) Enters the AI Cooling Market with New RefrigerantsYahoo Finance